drugset / Trial / NCT00083408
Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this research is to study how helpful the combination of thalidomide and Pamidronate is in controlling multiple myeloma and to study any side effects that may be experienced.
Timeline
- Start
- 1998-03
- Primary completion
- —
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pamidronate | Small molecule | — | — |
| Subject | Thalidomide | Other / unclassified | — | — |